Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
94,854,554
-
Share change
-
+14,221,756
-
Total reported value
-
$4,360,458,912
-
Put/Call ratio
-
139%
-
Price per share
-
$46.00
-
Number of holders
-
220
-
Value change
-
+$660,704,567
-
Number of buys
-
128
-
Number of sells
-
109
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q2 2017
As of 30 Jun 2017,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
220 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,854,554 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, and Invesco Ltd..
This page lists
220
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.